Axiom Bio
Home - Axiom
United States · Founded 2023 · $15.0M raised
- Employees
- 1–10
- Founded
- 2023
- Business Model
- B2B
- Website
- axi.om
- Total Funding
- $15.0M
- Last Round
- $15.0M SeedApr 2025
- Rounds
- 1
About
AI-powered biotech company building translational intelligence to replace animal testing and predict human drug toxicity.
Summary
Axiom Bio is an Artificial Intelligence company based in United States, founded in 2023. It has raised $15.0M in total across 1 round, most recently a $15.0M Seed round in Apr 2025. Investors include Amplify Partners, Dimension Capital and Zetta Venture Partners.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2025
Investors
Similar Companies

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

Scientific superintelligence platform building autonomous AI labs for life, chemical, and materia...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/axiom-bio"><img src="https://indexed.vc/api/badge/company/axiom-bio" alt="Axiom Bio on Indexed.vc" width="260" height="76" /></a>
